These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 33464392)
81. Bone mineral density changes during treatment of rheumatoid arthritis with disease-modifying-anti-rheumatic drugs. Heidari B; Monadi M; Ghazi Mirsaed MA Caspian J Intern Med; 2012; 3(1):354-7. PubMed ID: 26557285 [TBL] [Abstract][Full Text] [Related]
82. Bone density in rheumatoid arthritis. Noorwali AA Saudi Med J; 2004 Jun; 25(6):766-9. PubMed ID: 15195208 [TBL] [Abstract][Full Text] [Related]
83. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Minaur NJ; Kounali D; Vedi S; Compston JE; Beresford JN; Bhalla AK Rheumatology (Oxford); 2002 Jul; 41(7):741-9. PubMed ID: 12096222 [TBL] [Abstract][Full Text] [Related]
84. Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials. Siu S; Haraoui B; Bissonnette R; Bessette L; Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Kraft J; Lynde C; Gulliver W; Keeling S; Dutz J; Pope JE Arthritis Care Res (Hoboken); 2015 May; 67(6):754-64. PubMed ID: 25418272 [TBL] [Abstract][Full Text] [Related]
85. Soft tissue composition, axial bone mineral density, and grip strength in postmenopausal Turkish women with early rheumatoid arthritis: Is lean body mass a predictor of bone mineral density in rheumatoid arthritis? Sahin G; Guler H; Incel N; Sezgin M; As I Int J Fertil Womens Med; 2006; 51(2):70-4. PubMed ID: 16881382 [TBL] [Abstract][Full Text] [Related]
86. Is attenuated COBRA treatment strategy (COBRA-light) non-inferior or not non-inferior than original COBRA strategy? Akar S; Tinazli M Clin Exp Rheumatol; 2014; 32(6 Suppl 87):S-18. PubMed ID: 25327510 [No Abstract] [Full Text] [Related]
87. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Rahim A; Holmes SJ; Adams JE; Shalet SM Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413 [TBL] [Abstract][Full Text] [Related]
88. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies. Mustila A; Korpela M; Haapala AM; Kautiainen H; Laasonen L; Möttönen T; Leirisalo-Repo M; Ilonen J; Järvenpää S; Luukkainen R; Hannonen P Clin Exp Rheumatol; 2011; 29(3):500-5. PubMed ID: 21640044 [TBL] [Abstract][Full Text] [Related]
89. Bone mineral density in older adult patients with rheumatoid arthritis: an analysis of NHANES III. Kinjo M; Setoguchi S; Solomon DH J Rheumatol; 2007 Oct; 34(10):1971-5. PubMed ID: 17896806 [TBL] [Abstract][Full Text] [Related]
90. The COBRA trial 20 years later. Boers M Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S46-51. PubMed ID: 22018183 [TBL] [Abstract][Full Text] [Related]
91. The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis. Briot K; Rouanet S; Schaeverbeke T; Etchepare F; Gaudin P; Perdriger A; Vray M; Steinberg G; Roux C Joint Bone Spine; 2015 Mar; 82(2):109-15. PubMed ID: 25557658 [TBL] [Abstract][Full Text] [Related]
92. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial. Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382 [TBL] [Abstract][Full Text] [Related]
93. Are glucocorticoids harmful to bone in early rheumatoid arthritis? Lems WF Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059 [TBL] [Abstract][Full Text] [Related]
94. Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis. de Jong TD; Snoek T; Mantel E; van der Laken CJ; van Vollenhoven RF; Lems WF Front Immunol; 2019; 10():902. PubMed ID: 31068954 [No Abstract] [Full Text] [Related]
95. The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis. Chen JF; Hsu CY; Yu SF; Ko CH; Chiu WC; Lai HM; Chen YC; Su YJ; Cheng TT Rheumatology (Oxford); 2020 Sep; 59(9):2471-2480. PubMed ID: 31984422 [TBL] [Abstract][Full Text] [Related]
96. Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis. Güler-Yüksel M; Klarenbeek NB; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van der Kooij SM; Gerards AH; Ronday HK; Huizinga TW; Dijkmans BA; Allaart CF; Lems WF Arthritis Res Ther; 2010; 12(3):R96. PubMed ID: 20482894 [TBL] [Abstract][Full Text] [Related]
97. Effect of long-term low dose prednisolone administration on bone mineral density: Relating to non-compliant women with rheumatoid arthritis. Heidari B; Heidari P; Hajian-Tilaki K; Bayani MA; Babaei M Caspian J Intern Med; 2018; 9(2):171-177. PubMed ID: 29732036 [TBL] [Abstract][Full Text] [Related]
98. Effects of Locomotion Training on Bone Mineral Density in Patients with Rheumatoid Arthritis. Mochizuki T; Yano K; Ikari K; Okazaki K Prog Rehabil Med; 2024; 9():20240022. PubMed ID: 38895591 [TBL] [Abstract][Full Text] [Related]
99. Measurement of bone mineral density by dual energy X-ray absorptiometry in juvenile idiopathic arthritis. Dey S; Jahan A; Yadav TP; Bhagwani DK; Sachdev N Indian J Pediatr; 2014 Feb; 81(2):126-32. PubMed ID: 23645223 [TBL] [Abstract][Full Text] [Related]
100. Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial. Pazmino S; Boonen A; De Cock D; Stouten V; Joly J; Bertrand D; Westhovens R; Verschueren P RMD Open; 2021 May; 7(2):. PubMed ID: 34031262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]